as on February 6, 2026 at 2:29 am IST
Day's Low
Day's High
1.96%
Downside
4.58%
Upside
52 Week's Low
52 Week's High
45.54%
Downside
262.75%
Upside
Check Pyxis Oncology, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$100.2M
EPS (TTM)
-1.3011
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-80.5M
Revenue (TTM)
2.8M
Profit Margin
0.00%
Return On Equity TTM
-87.28%
Compare market cap, revenue, PE, and other key metrics of Pyxis Oncology, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $100.2M | NA | NA | 0.00% | |
| BUY | $122.3B | 113.14% | 33.56 | 31.35% | |
| BUY | $47.7B | 100.62% | 1246.03 | 1.36% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 53.64% | 18.28 | 32.13% |
The Pyxis Oncology, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Pyxis Oncology, Inc. investment value today
Current value as on today
₹1,07,450
Returns
₹7,450
(+7.45%)
Returns from Pyxis Oncology, Inc. Stock
₹4,082 (+4.08%)
Dollar Returns*
₹3,368 (+3.37%)
Based on 13 analysts
92.31%
Buy
7.69%
Hold
0.00%
Sell
Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Pyxis Oncology, Inc.. Average target price of $6.92
Get share price movements and forecasts by analysts on Pyxis Oncology, Inc..
What analysts predicted
77.89%UPSIDE
Target Price
$6.92
Current Price
$1.53
Analyzed by
13 Analysts
Target
$6.92
Pyxis Oncology, Inc. target price $6.92, a slight upside of 77.89% compared to current price of $1.53. According to 13 analysts rating.
Search interest for Pyxis Oncology, Inc. Stock has increased by 57% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:57% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 53.8% return, outperforming this stock by 51.1%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 43.6% return, outperforming this stock by 49.2%
Price Dip
![]()
In the last 3 months, PYXS stock has moved down by -62.6%
| Organisation | Pyxis Oncology, Inc. |
| Headquarters | 321 Harrison Avenue, Boston, MA, United States, 02118 |
| Industry | Services |
| CEO | Dr. Lara S. Sullivan M.D., MBA |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Alex Kane M.B.A. | Senior Vice President of Investor Relations & Capital Markets |
Donna Regalado | Head of Human Resources |
Mr. Stephen T. Worsley MBA | Senior VP & Chief Business Officer |
Dr. Supriya Roth Ph.D. | Head of Commercial Development |
Dr. Lara S. Sullivan M.D., MBA | CEO, President, Chief Medical Officer & Director |
Mr. Jitendra Wadhane C.A., CPA | Chief Accounting Officer, Senior VP of Finance, Corporate Controller & Principal Financial Officer |
Dr. Balu N. Balasubramanian Ph.D. | Interim Chief Technology Officer |
Dr. Jan Pinkas Ph.D. | Chief Scientific Officer |
Dr. Charles T. Gombar Ph.D. | Senior Vice President of Portfolio & Program Management |
Dr. Michael Bui | Head of Global Regulatory Affairs |
Pyxis Oncology, Inc. share price today is $1.53 as on at the close of the market. Pyxis Oncology, Inc. share today touched a day high of $1.6 and a low of $1.5.
Pyxis Oncology, Inc. share touched a 52 week high of $5.55 on and a 52 week low of $0.83 on . Pyxis Oncology, Inc. stock price today i.e. is closed at $1.53,which is 72.43% down from its 52 week high and 83.63% up from its 52 week low.
Pyxis Oncology, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Pyxis Oncology, Inc. (PYXS) shares with as little as ₹90.283 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹902.83 in Pyxis Oncology, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Pyxis Oncology, Inc. share’s latest price of $1.53 as on February 6, 2026 at 2:29 am IST, you will get 6.5359 shares of Pyxis Oncology, Inc.. Learn more about
fractional shares .